PLIANT THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": 226854000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | PLIANT THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:48:42.383055+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0665f2e9-4fb0-4b0e-993a-784d6f33f67a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001746473-23-000008 · Open the official SEC filing →Retrieved: 2026-08-19T17:48:42.383055+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001746473/cashflow-financing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0665f2e9-4fb0-4b0e-993a-784d6f33f67a
History
- no predecessors — first report